# Evaluating In Home Cancer Therapy Versus In Clinic Cancer Therapy in Black Men With Locally Advanced, Biochemically Recurrent and Metastatic Prostate Cancer

> **NCT07073794** · PHASE2 · RECRUITING · sponsor: **Mayo Clinic** · enrollment: 38 (estimated)

## Conditions studied

- Biochemically Recurrent Prostate Carcinoma
- Locally Advanced Prostate Carcinoma
- Metastatic Prostate Carcinoma
- Stage III Prostate Cancer AJCC v8
- Stage IV Prostate Cancer AJCC v8

## Interventions

- **DRUG:** Cancer Therapeutic Procedure
- **DRUG:** Cancer Therapeutic Procedure
- **OTHER:** Health Care Delivery
- **OTHER:** Questionnaire Administration

## Key facts

- **NCT ID:** NCT07073794
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-08-27
- **Primary completion:** 2028-08-27
- **Final completion:** 2028-08-27
- **Target enrollment:** 38 (ESTIMATED)
- **Last updated:** 2026-03-25

## Collaborators

- Congressionally Directed Medical Research Programs

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07073794

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07073794, "Evaluating In Home Cancer Therapy Versus In Clinic Cancer Therapy in Black Men With Locally Advanced, Biochemically Recurrent and Metastatic Prostate Cancer". Retrieved via AI Analytics 2026-07-02 from https://api.ai-analytics.org/clinical/NCT07073794. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*